These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1972893)

  • 1. Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat.
    Valenta B; Singer EA
    Br J Pharmacol; 1990 Apr; 99(4):713-6. PubMed ID: 1972893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B; Kotai E; Weisz E; Singer EA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Hibert M; van den Buuse M
    Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors.
    Mandal AK; Zhong PY; Kellar KJ; Gillis RA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S49-60. PubMed ID: 1702487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs.
    Laubie M; Drouillat M; Dabiré H; Cherqui C; Schmitt H
    Eur J Pharmacol; 1989 Feb; 160(3):385-94. PubMed ID: 2523813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
    Gradin K; Pettersson A; Hedner T; Persson B
    J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central presynaptic receptors].
    Singer EA; Valenta B; Kotai E; Drobny H; Weisz E
    Wien Klin Wochenschr; 1990 Oct; 102(20):609-15. PubMed ID: 1979459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the rat.
    Helke CJ; McDonald CH; Phillips ET
    J Auton Nerv Syst; 1993 Feb; 42(2):177-88. PubMed ID: 8450176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
    Borbe HO; Metzenauer P; Szelenyi I
    Eur J Pharmacol; 1991 Nov; 205(1):105-7. PubMed ID: 1839829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice.
    Moser PC
    Eur J Pharmacol; 1991 Feb; 193(2):165-72. PubMed ID: 1828767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats.
    Dabire H; Cherqui C; Fournier B; Schmitt H
    Eur J Pharmacol; 1987 Aug; 140(3):259-66. PubMed ID: 2958302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor effects following microinjection of 5-HT1A receptor agonists into the raphe obscurus of the anaesthetized rat.
    Dreteler GH; Wouters W; Saxena PR; Ramage AG
    Br J Pharmacol; 1991 Feb; 102(2):317-22. PubMed ID: 1673069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects following injection of 8-OH-DPAT and flesinoxan into the dorsal raphe nucleus of conscious rats.
    Connor HE; Higgins GA
    Br J Pharmacol; 1989 Dec; 98 Suppl():810P. PubMed ID: 2532943
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx.
    King KA; Holtman JR
    J Pharmacol Exp Ther; 1990 Feb; 252(2):665-74. PubMed ID: 2138222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.